4//SEC Filing
Curran Terrie 4
Accession 0001209191-23-054346
CIK 0001783183other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:53 PM ET
Size
5.6 KB
Accession
0001209191-23-054346
Insider Transaction Report
Form 4
Curran Terrie
DirectorPresident and Chief Executive
Transactions
- Award
Common Stock
2023-11-01+37,500→ 427,171 total
Holdings
- 3,579.61(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Represents shares earned with respect to performance stock unit awards granted on July 1, 2020 and January 19, 2023 that contained a performance-vesting requirement that was satisfied on November 1, 2023.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001690298
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:53 PM ET
- Size
- 5.6 KB